WINTON GROUP Ltd Makes New $354,000 Investment in MiMedx Group, Inc. (NASDAQ:MDXG)

WINTON GROUP Ltd bought a new position in MiMedx Group, Inc. (NASDAQ:MDXG) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 51,023 shares of the company’s stock, valued at approximately $354,000.

Other large investors have also recently added to or reduced their stakes in the company. Headlands Technologies LLC acquired a new stake in MiMedx Group in the first quarter worth $27,000. Quest Partners LLC acquired a new stake in MiMedx Group in the second quarter worth $81,000. Entropy Technologies LP acquired a new stake in MiMedx Group in the first quarter worth $99,000. Shell Asset Management Co. acquired a new stake in MiMedx Group in the first quarter worth $113,000. Finally, Victory Capital Management Inc. grew its stake in shares of MiMedx Group by 23.1% in the fourth quarter. Victory Capital Management Inc. now owns 14,916 shares of the company’s stock worth $131,000 after purchasing an additional 2,796 shares in the last quarter. 79.15% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

MDXG has been the subject of several recent analyst reports. StockNews.com raised MiMedx Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $11.00 price target on shares of MiMedx Group in a research note on Thursday, August 1st. Finally, Craig Hallum decreased their price target on MiMedx Group from $14.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $12.00.

MiMedx Group Trading Up 0.5 %

Shares of MDXG stock opened at $6.18 on Thursday. MiMedx Group, Inc. has a fifty-two week low of $5.57 and a fifty-two week high of $9.27. The stock has a market capitalization of $912.19 million, a P/E ratio of 14.05 and a beta of 1.98. The company has a quick ratio of 3.22, a current ratio of 3.85 and a debt-to-equity ratio of 0.11. The stock has a 50-day simple moving average of $6.71 and a 200 day simple moving average of $7.04.

MiMedx Group (NASDAQ:MDXG) last announced its earnings results on Wednesday, July 31st. The company reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. MiMedx Group had a return on equity of 34.24% and a net margin of 23.63%. The business had revenue of $87.21 million during the quarter, compared to the consensus estimate of $88.44 million. On average, sell-side analysts expect that MiMedx Group, Inc. will post 0.26 earnings per share for the current fiscal year.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.